Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 7 of 7 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Clear Filters
Adenovirus Vaccine Pregnancy Registry
- Condition(s):
- Adenovirus
- Status:
- Withdrawn
- Requirements:
- 17 Years to 50 Years
PD, PK, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors
- Condition(s):
- Solid Tumors
- Status:
- Withdrawn
- Requirements:
- 2 Years to 17 Years
- Interventions:
- Drug: Balugrastim | Drug: Filgrastim
Randomized, Double-blind, Placebo-controlled Study Assessing Safety and Tolerability of Laquinimod
- Condition(s):
- Relapsing Multiple Sclerosis
- Status:
- Withdrawn
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Laquinimod 0.6 | Drug: Laquinimod 1.2 | Other: Glatiramer Acetate or interferon-beta+ Placebo
Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
- Condition(s):
- Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus
- Status:
- Withdrawn
- Requirements:
- 18 Years to 65 Years
- Interventions:
- Drug: TEV-45478 | Drug: Placebo
Study of Fremanezumab in Patients With Interstitial Cystitis-Bladder Pain Syndrome
- Condition(s):
- Interstitial Cystitis
- Status:
- Withdrawn
- Requirements:
- 18 Years and older
- Interventions:
- Drug: fremanezumab
Study of Tiotropium Hydrofluoralkane in Patients With Chronic Obstructive Pulmonary Disease
- Condition(s):
- Chronic Obstructive Pulmonary Disease | COPD
- Status:
- Withdrawn
- Requirements:
- 40 Years to 80 Years
- Interventions:
- Drug: Tiotropium HFA BAI 5 mcg | Drug: Tiotropium 18 mcg Capsule | Drug: Placebo
Study to Evaluate Laquinimod Compared to Interferon ß-1a Administered by Injection
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Withdrawn
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Laquinimod | Drug: Avonexֲ®
